FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes
pharmaceutical investing Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
Brixton Metals Announces Upsize of Previously Announced Non-Brokered Private Placement to $8 Million and Closing of Second Tranche
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026